Contribute Try STAT+ Today

WASHINGTON — Even before it was announced, drug makers threatened to sue the Trump administration over a new policy that would require them to include prices in their TV ads.

Now that the proposal is official, the better question about a lawsuit may be “When?” Already on Monday, drug makers doubled down on their argument that the government is violating their First Amendment rights by compelling them to disclosure their prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • No violations of first amendment rights in the required posting of prices. The goal is “public right to know “. Everything for sale is promoted with a price and price competition is routine business.

  • A few weeks ago, our predatory Pharma Industry and their sycophant Azar, were complaining about listing the Side Effects on their products. This deceptive advertising used to be Illegal in the US food for good reason. Drug prices are still rising exponentially and price gouging, is now a perfectly acceptable business practice. Our media normalized all of this and continues to misinform the public.

Comments are closed.